XML 81 R7.htm IDEA: XBRL DOCUMENT v3.25.1
CONSOLIDATED STATEMENTS OF STOCKHOLDERS’ DEFICIT - USD ($)
shares in Thousands, $ in Thousands
Total
Cumulative Effect, Period of Adoption, Adjusted Balance
Preferred Stock
Common Stock
Additional Paid-in Capital
Accumulated Other Comprehensive Loss
Accumulated Deficit
Accumulated Deficit
Cumulative Effect, Period of Adoption, Adjusted Balance
Beginning balance (in shares) at Dec. 31, 2022     876 1,407        
Beginning balance at Dec. 31, 2022 $ (477) $ (2) $ 0 $ 1 $ 148,545 $ (3) $ (149,020) $ (2)
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Issuance of common stock (in shares)       2,477        
Issuance of common stock 6,079     $ 1 6,078      
Stock issued in exchange transactions (in shares)       465        
Stock issued in exchange transactions 1,716       1,716      
Par value adjustment due to reverse stock split 0     $ (2) 2      
Reduction in equity due to costs from reverse stock split (16)       (16)      
Stock-based compensation 44       44      
Net loss (4,293)           (4,293)  
Ending balance (in shares) at Dec. 31, 2023     876 4,349        
Ending balance at Dec. 31, 2023 3,051   $ 0 $ 0 156,369 (3) (153,315)  
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Issuance of common stock (in shares)       818        
Issuance of common stock 1,301     $ 1 1,300      
Conversion of advanced capital contribution to common stock (in shares)       94        
Conversion of advanced capital contribution to common stock 141       141      
Stock-based compensation 4       4      
Net loss (1,582)           (1,582)  
Ending balance (in shares) at Dec. 31, 2024     876 5,261        
Ending balance at Dec. 31, 2024 $ 2,915   $ 0 $ 1 $ 157,814 $ (3) $ (154,897)